156 related articles for article (PubMed ID: 8985224)
1. Role of macrophages in the candidacidal activity of liposomal amphotericin B.
Mehta RT; Poddar S; Kalidas M; Gomez-Flores R; Dulski K
J Infect Dis; 1997 Jan; 175(1):214-7. PubMed ID: 8985224
[TBL] [Abstract][Full Text] [Related]
2. Influence of free or liposomal amphotericin B on killing of Candida species by human peritoneal macrophages.
Allwinn R; Schaumann R; Shah PM
Methods Find Exp Clin Pharmacol; 1995 Apr; 17(3):163-7. PubMed ID: 8531506
[TBL] [Abstract][Full Text] [Related]
3. Interactions of liposomal amphotericin B with extracellular and intracellular Candida albicans.
van Etten EW; Chander HR; Snijders SV; Bakker-Woudenberg IA
J Antimicrob Chemother; 1995 Dec; 36(6):961-74. PubMed ID: 8821595
[TBL] [Abstract][Full Text] [Related]
4. Activity of liposomal amphotericin B with prolonged circulation in blood versus those of AmBisome and fungizone against intracellular Candida albicans in murine peritoneal macrophages.
van Etten EW; van Vianen W; Hak J; Bakker-Woudenberg IA
Antimicrob Agents Chemother; 1998 Sep; 42(9):2437-9. PubMed ID: 9736579
[TBL] [Abstract][Full Text] [Related]
5. Activity of amphotericin B and intraconazole against intraphagocytic Candida albicans.
Ponce E; Pechère JC
Eur J Clin Microbiol Infect Dis; 1990 Oct; 9(10):738-44. PubMed ID: 2175704
[TBL] [Abstract][Full Text] [Related]
6. A sub-inhibitory concentration of amphotericin B enhances candidastatic activity of interferon-gamma- and interleukin-13-treated murine peritoneal macrophages.
Coste A; Linas MD; Cassaing S; Bernad J; Chalmeton S; Séguéla JP; Pipy B
J Antimicrob Chemother; 2002 May; 49(5):731-40. PubMed ID: 12003965
[TBL] [Abstract][Full Text] [Related]
7. Uptake and killing of Candida by human peritoneal macrophages and amphotericin B.
Linde HJ; Stille W; Shah PM
Methods Find Exp Clin Pharmacol; 1994 Mar; 16(2):79-84. PubMed ID: 8007745
[TBL] [Abstract][Full Text] [Related]
8. In-vitro effects of liposome-encapsulated amphotericin B (AmBisome) and amphotericin B-deoxycholate (Fungizone) on the phagocytic and candidacidal function of human polymorphonuclear leucocytes.
Pallister CJ; Johnson EM; Warnock DW; Elliot PJ; Reeves DF
J Antimicrob Chemother; 1992 Sep; 30(3):313-20. PubMed ID: 1452496
[TBL] [Abstract][Full Text] [Related]
9. Graphene oxide nanosheets increase Candida albicans killing by pro-inflammatory and reparative peritoneal macrophages.
Diez-Orejas R; Feito MJ; Cicuéndez M; Casarrubios L; Rojo JM; Portolés MT
Colloids Surf B Biointerfaces; 2018 Nov; 171():250-259. PubMed ID: 30036792
[TBL] [Abstract][Full Text] [Related]
10. Effect of amphotericin B, fluconazole and itraconazole on intracellular Candida albicans and germ tube development in macrophages.
Van 't Wout JW; Meynaar I; Linde I; Poell R; Mattie H; Van Furth R
J Antimicrob Chemother; 1990 May; 25(5):803-11. PubMed ID: 2165051
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of liposomal amphotericin B against four species of Candida biofilms in an experimental mouse model of intravascular catheter infection.
Fujimoto K; Takemoto K
J Infect Chemother; 2018 Dec; 24(12):958-964. PubMed ID: 30209024
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo antifungal activities of liposomal amphotericin B, and amphotericin B lipid complex.
Mitsutake K; Kohno S; Miyazaki Y; Noda T; Miyazaki H; Miyazaki T; Kaku M; Koga H; Hara K
Mycopathologia; 1994 Oct; 128(1):13-7. PubMed ID: 7708087
[TBL] [Abstract][Full Text] [Related]
13. Comparative capacity of four antifungal agents to stimulate murine macrophages to produce tumour necrosis factor alpha: an effect that is attenuated by pentoxifylline, liposomal vesicles, and dexamethasone.
Louie A; Baltch AL; Franke MA; Smith RP; Gordon MA
J Antimicrob Chemother; 1994 Dec; 34(6):975-87. PubMed ID: 7730240
[TBL] [Abstract][Full Text] [Related]
14. Anti-biofilm activity of a sophorolipid-amphotericin B niosomal formulation against Candida albicans.
Haque F; Sajid M; Cameotra SS; Battacharyya MS
Biofouling; 2017 Oct; 33(9):768-779. PubMed ID: 28946803
[TBL] [Abstract][Full Text] [Related]
15. Candidacidal activity of macrophages from immunocompetent and congenitally immunodeficient mice.
Vazquez-Torres A; Jones-Carson J; Balish E
J Infect Dis; 1994 Jul; 170(1):180-8. PubMed ID: 8014495
[TBL] [Abstract][Full Text] [Related]
16. Effect of mycolase and amphotericin B on Candida albicans and Candida pseudotropicalis in vitro and in vivo.
Chalkley LJ; Trinci AP; Pope AM
Sabouraudia; 1985 Jun; 23(3):147-64. PubMed ID: 3895468
[TBL] [Abstract][Full Text] [Related]
17. [Dormancy of Candida albicans ATCC10231 in the presence of amphotericin B. Investigation using the scanning electron microscope (SEM)].
Benmansour W; Boucherit-Otmani Z; Boucherit K
J Mycol Med; 2014 Sep; 24(3):e93-100. PubMed ID: 24768064
[TBL] [Abstract][Full Text] [Related]
18. High-dose methylprednisolone influences the physiology and virulence of Candida albicans ambiguously and enhances the candidacidal activity of the polyene antibiotic amphotericin B and the superoxide-generating agent menadione.
Gyetvai A; Emri T; Fekete A; Varga Z; Gazdag Z; Pesti M; Belágyi J; Emõdy L; Pócsi I; Lenkey B
FEMS Yeast Res; 2007 Mar; 7(2):265-75. PubMed ID: 17266730
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro studies on liposomal formulations of amphotericin B and its derivative, N-methyl-N-D-fructosyl amphotericin B methyl ester (MFAME).
Cybulska B; Kupczyk K; Szlinder-Richert J; Borowski E
Acta Biochim Pol; 2002; 49(1):67-75. PubMed ID: 12136958
[TBL] [Abstract][Full Text] [Related]
20. Effects of dosing regimen on accumulation, retention and prophylactic efficacy of liposomal amphotericin B.
Smith PJ; Olson JA; Constable D; Schwartz J; Proffitt RT; Adler-Moore JP
J Antimicrob Chemother; 2007 May; 59(5):941-51. PubMed ID: 17400589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
